A.R.T. Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

A.R.T. Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7	Closed	-$58K	–	1788
2019 Q2	$58K	Buy	+7	New	+$82K	﹤0.01%	1239
2018 Q4	–	Sell	-9	Closed	-$319K	–	1740
2018 Q3	$319K	Buy	+9	New	+$296K	0.01%	1019
2015 Q4	–	Sell	-5	Closed	-$214K	–	1773
2015 Q3	$214K	Buy	5 +2	+67%	+$133K	0.01%	1148
2015 Q2	$262K	Hold	3	–	–	0.01%	1217
2015 Q1	$194K	Buy	+3	New	+$279K	0.01%	1240

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

A.R.T. Advisors's TTOO Position: Q3 2019 in Review

A.R.T. Advisors sold out of T2 Biosystems, Inc (TTOO) in Q3 2019, closing a stake of 7 shares — an estimated $58K sold.

A.R.T. Advisors first reported a position in TTOO in Q1 2015 and held it in 5 quarters. The position peaked at $319K in Q3 2018. 48 funds tracked by Wall St. Rank hold TTOO as of Q3 2019.

A.R.T. Advisors reported no remaining T2 Biosystems, Inc position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 7 T2 Biosystems, Inc shares in Q3 2019, an estimated $58K.
A.R.T. Advisors first reported a position in T2 Biosystems, Inc in Q1 2015 and held it in 5 quarters.
A.R.T. Advisors's T2 Biosystems, Inc position peaked at $319K in Q3 2018.
48 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.